Reckitt Benckiser

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Reckitt Benckiser sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 8 completed later-stage tilt upper quartile by trial count

Reckitt Benckiser: 8 sponsored US clinical trials, none currently recruiting.

Reckitt Benckiser sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 5 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acute Pharyngitis, with 1 trials.

Upper-quartile sponsor footprint

Reckitt Benckiser sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

COMPLETED Phase 3

Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method

NCT01986361
COMPLETED Phase 2

Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections

NCT01537081
COMPLETED Phase 2

Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection

NCT01114581
COMPLETED Phase 2

Mucinex Exploratory Cold Study

NCT01046136
COMPLETED Phase 3

A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis

NCT01049334
COMPLETED Phase 3

A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

NCT01048866
COMPLETED Phase 4

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

NCT01202279
COMPLETED Phase 3

Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study

NCT01229449

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 4
Phase 4 1

Therapeutic Areas

Acute Pharyngitis 1
Sore-throat 1

How the Reckitt Benckiser archive is shaped

8 indexed studies, none listed as recruiting (0% open); 8 completed (100%).

Phase mix: 5 late (III/IV) vs 3 early (I/II) (later-stage heavy).

Top condition: Acute Pharyngitis (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Reckitt Benckiser: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Reckitt Benckiser sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Reckitt BenckiserAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
Reckitt Benckiser sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Reckitt Benckiser sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Reckitt Benckiser page

8 registered trials is a research-attention snapshot, not an endorsement of Reckitt Benckiser or any single study.

  • None of Reckitt Benckiser's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Acute Pharyngitis is the condition Reckitt Benckiser studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Pharyngitis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Reckitt Benckiser pipeline card: 8 registered trials from official public datasets.Report a data error.